1. Huang, C, Wang, Y, Li, X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506.
Google Scholar | Crossref | Medline2. Li, Q, Guan, X, Wu, P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; 382: 1199–1207.
Google Scholar | Crossref | Medline3. World Health Organization. Coronavirus disease (COVID-2019) situation reports . Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200313-sitrep-53-covid-19.pdf?sfvrsn=adb3f72_2. (accessed March 2020).
Google Scholar4. Ficarra, V, Novara, G, Abrate, A, et al. Urology practice during COVID-19 174 pandemic Minerva Urol Nefrol. In press. https://doi.org/10.23736/S0393-2249.20.03846-1.175
Google Scholar5. Boehm*, Katharina, Ziewers, Stefani, Brandt, Maximilian P., Sparwasser, Peter, Haack, Maximilian, Willems, Franziska, Thomas, Anita, Dotzauer, Robert, Ho¨fner, Thomas, Tsaur, Igor, Haferkamp, Axel, Hendrik Borgmann :Telemedicine Online Visits in Urology During the COVID-19 Pandemic—Potential, Risk Factors, and Patients’ Perspective, doi:https://doi.org/10.1016/j.eururo.2020.04.055.
Google Scholar6. Miller, A, Rhee, E, Gettman, M, et al. The current state of telemedicine 176 in urology. Med Clin North Am 2018; 102: 387–398.
Google Scholar | Crossref | Medline7. Larson, JL, Rosen, AB, Wilson, FA. The effect of telehealth interventions 180 on quality of life of cancer patients: a systematic review and meta-analysis. Telemed J E Health 2018; 24: 397–405.
Google Scholar | Crossref | Medline8. Yang, Guang, Xu, Yong, Qu, Genyi, Zhang, Yulong. Refractory overactive bladder patients who chose sacral neuromodulation therapy after failed OnabotulinumtoxinA treatment: A systematic review and meta-analysis Meta-Analysis PLoS One. 2020 Mar 30;15(3):e0230355. doi: 10.1371/journal.pone.0230355. eCollection 2020.
Google Scholar | Crossref9. Lo, Chi-Wen, Wu, Mei-Yi, Yang, Stephen Shei-Dei, et al. Comparing the Efficacy of OnabotulinumtoxinA, Sacral Neuromodulation, and Peripheral Tibial Nerve Stimulation as Third Line Treatment for the Management of Overactive Bladder Symptoms in Adults: Systematic Review and Network Meta-Analysis. Toxins (Basel). 2020; 12: 128.
Google Scholar | Crossref10. Meng, Ling-Feng, Zhang, Wei, Wang, Jian-Ye, et al. Clinical outcomes of sacral neuromodulation in non-neurogenic, non-obstructive dysuria: A 5-year retrospective, multicentre study in China, World J Clin Cases 2020; 8: 2494–2501.
Google Scholar | Crossref | Medline11. Mahran, A, Baaklini, G, Hassani, D, et al. Sacral neuromodulation treating chronic pelvic pain: a meta-analysis and systematic review of the literature. Int Urogynecol J 2019; 30: 1023–1035.
Google Scholar | Crossref | Medline12. Lai-Fung, Li, Ka-Kit Leung, Gilberto, Wai-Man Lui Sacral Nerve Stimulation for Neurogenic Bladder. Review World Neurosurg 2016; 90: 236–243.
Google Scholar | Crossref | Medline13. Mahran, A, Soriano, A, Safwat, AS, et al. The effect of sacral neuromodulation on pregnancy: a systematic review. Int Urogynecol J. 2017; 28: 1357–1365.
Google Scholar | Crossref | Medline14. Wright, Anne J , Mirna Haddad Electroneurostimulation for the management of bladder bowel dysfunction in childhood, Review Eur J Paediatr Neurol 2017; 21: 67–74.
Google Scholar | Crossref | Medline15. Bekkers, E, Koopman, RB. Simulating the trade effects of the COVID-19 pandemic: Scenario analysis based on quantitative trade modelling. World Econ. Epub ahead of print 8 December 2020. DOI: 10.1111/twec.13063.
Google Scholar16. Evenett, S, Fiorini, M, Fritz, J, et al. Trade policy responses to the COVID-19 pandemic crisis: Evidence from a new data set. World Econ. Epub ahead of print 15 March 2021. DOI: 10.1111/twec.13119.
Google Scholar